In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. - Wikidata - wikimedia - TriplyDB

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

http://www.wikidata.org/entity/Q33942238

about

A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40 IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke.Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.Profiling the genes affected by pathogenic TDP-43 in astrocytes Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African children Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells.Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease.Outer brain barriers in rat and human development.Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer.Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease Exacerbation of experimental autoimmune encephalomyelitis in the absence of breast regression protein 39/chitinase 3-like 1.Preventive immunization of aged and juvenile non-human primates to β-amyloid Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation.Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.SSEA-4 and YKL-40 positive progenitor subtypes in the subventricular zone of developing human neocortex Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.Brain barriers and a subpopulation of astroglial progenitors of developing human forebrain are immunostained for the glycoprotein YKL-40.Glia-based biomarkers and their functional role in the CNS.High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease.HIV/neuroAIDS biomarkers.Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis.Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases.Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Effect of carotid endarterectomy on brain damage markers.YKL-40 acts as an angiogenic factor to promote tumor angiogenesis.

P2860

Q24624033-18161BB5-D0AE-461D-987E-583DFC55AD30 Q27497796-8A77730F-3C17-440E-8FAB-1609EC21E07E Q28257420-9C9A8643-882B-414D-949C-1B5B0D0E5A8C Q33689233-3F78AEBA-B2F2-4D23-87AB-42D4ED2832DD Q33769278-648CB75C-49F4-4CE3-9C7F-8E591B3D3F3F Q33784904-1956EF77-2221-4012-9374-759007C1F64B Q33789456-63FD59F1-20D7-4C40-9AAE-F5F9D672A40A Q33965057-8C27737D-A8F9-4BCA-8736-2E6A383A7D92 Q34181135-B9557448-533D-487A-BEC9-241BEE78BCFA Q34447497-4ABE1A8C-2A01-4D23-8634-E986C7A5625E Q34525564-EBE0BA1A-4B0D-4FB8-85D2-52EAE8682678 Q34720622-28E52CFE-6DAF-4E9C-8E57-F2384A657AD3 Q35015106-235B8026-0289-4813-B312-36D4EF7104BF Q35099962-28F88556-722E-4E03-8C8D-67E09C98A96B Q35179599-122767BC-C434-4502-99E5-D8138A34309A Q35330799-68263246-583E-4A1A-B65D-8D01D48C082A Q35745168-CFC66C86-B440-48D9-B227-A491899BD64A Q35746711-A4559F55-5CB0-4D99-BA5F-76306C61C615 Q36071742-EFCE31DA-8F9E-476D-AB6F-9FAA9AE81E9D Q36189198-2B59C46E-2989-40E2-8AAC-0E8010D17ABD Q36263876-03CFABC1-C933-44F1-BB1B-423A4A90F4AB Q36337525-0F34BBCA-D0F6-485A-A319-D5C4E656CFDB Q36346806-D0C18B6C-5B50-4180-9318-DA2B84569055 Q36391157-554A2AD4-C7C2-4F84-88B1-0F91B5C0BB49 Q36568996-BB45477C-28EE-46DA-8FE6-021826BAAF53 Q36913222-7048A168-2BC3-4747-A71E-90CF67DD0FAF Q37308951-AAAB5801-F8A3-4997-9A73-E738B06098AF Q37345484-A1AEFC8D-F210-4BFE-9694-004B6CDD0B42 Q37565386-1A1FD68C-284F-412C-8182-77DBB6A0AEA7 Q37733730-054937FE-543B-4728-A40C-C97EF851238C Q38081955-76B98E97-E8DD-43A8-9B10-25E0FD3B8907 Q38433342-0C4F3488-D1FF-40EE-9B8E-FD3E85F4755C Q38590773-3E11F169-72C1-4962-BCE3-D6090EE5B7A9 Q38759253-7D1CC480-CC39-4FA9-BAA5-186B9153391D Q38809646-A8B6313A-AF2E-45C9-A7DD-FEB5525C6111 Q38811271-27071BCA-DD43-4B0E-B2D6-EE68E4BD9B72 Q38836316-E9217BEF-2557-4BC5-820F-4401E60FA0CA Q38915171-5BB3B2ED-1E2F-4A03-AEC4-06756E1AA61F Q39811657-A5B34309-8171-49B2-AC4A-8CA70D550EF8 Q41073254-1C140DBE-E85B-442C-9CB3-4565E5B2AFAB

P2860

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

http://www.wikidata.org/entity/Q33942238

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@ast

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@en

type

label

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@ast

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@en

prefLabel

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@ast

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@en

P1433

Q33942238-DD2AD66B-69A4-4DE0-8FE1-D4B3D70F5620

P1476

Q33942238-F203F498-4DC6-40F7-B36A-615C227B7060

P2093

Q33942238-21E8FDA2-804B-49B8-949E-65174A3BDA78

Q33942238-512E7293-4A03-4A7F-8360-978EEC819CA5

Q33942238-8B8A3BE0-9D0E-4CB6-8B4A-7412475F7BE6

Q33942238-DFC572B6-5A21-4614-A99E-23BA5BBFCBD8

Q33942238-F46CCF0E-1B46-4FAE-9C34-5201A6A12422

P2860

Q33942238-007122C1-AFDF-47F3-92D9-3477BBFBD018

Q33942238-41C00302-198F-4BBF-9C9C-DF3CF4CF7DCD

Q33942238-4C69533B-3ADD-4D7D-BDDA-80FFA7EE5380

Q33942238-50D49718-78BE-4A70-BA8F-A3071B4417A6

Q33942238-5C64853D-E3BE-4140-AB90-2D618BED9997

Q33942238-64455C21-BB86-4202-91F2-CA6E36011EB8

Q33942238-730DB16F-C979-41BE-93F4-63390BC3F5CD

Q33942238-ABDDE8A1-C17E-44B3-94E6-56649BB66D7C

Q33942238-B13A9D81-72B9-4008-A51A-E3454A7BF2EC

Q33942238-BD2CBC13-FCA8-4DED-891D-662CC25F4344

P2888

Q33942238-8E78367A-0DF2-4040-A876-CD21244C9159

P304

Q33942238-00ABFD32-D7E1-47FE-B105-FDC1CD78A62A

P31

Q33942238-CC275802-316E-45D7-83C7-4079C9B63068

P356

Q33942238-F06E69E6-E284-48EA-AF25-1294A045EF11

P478

Q33942238-3C2C2A97-8472-469A-8B98-B8C8E1A7289E

P577

Q33942238-6E774D5F-4733-44BD-9A11-0A9D0829A15F

P5875

Q33942238-358431B7-B279-433C-A9F9-E111D7F4D85B

P6179

Q33942238-F1AE0934-9D77-493F-B53C-7092D9931871

P698

Q33942238-8B295B38-A1C2-4D27-B314-8F4788841883

P921

Q33942238-37a9ead3-90c4-4203-9a5c-f19ce841ab09

P932

Q33942238-BDFD199A-570C-49A3-998B-44B7B7D7D2B4

P356

P1433

Journal of Neuroinflammation

P1476

In vivo CHI3L1 (YKL-40) expres ...... chronic neurological diseases.

@en

P2093

Adam Starkey

http://www.w3.org/2001/XMLSchema#string

Clayton A Wiley

http://www.w3.org/2001/XMLSchema#string

Dafna Bonneh-Barkay

http://www.w3.org/2001/XMLSchema#string

Guoji Wang

http://www.w3.org/2001/XMLSchema#string

Ronald L Hamilton

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function

YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival

YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.

A chitinase-like protein in the lung and circulation of patients with severe asthma.

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD

Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia.

Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.

Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer.

P2888

P304

34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-7-34

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44666130

http://www.w3.org/2001/XMLSchema#string

P6179

1022608403

http://www.w3.org/2001/XMLSchema#string

P698

20540736

http://www.w3.org/2001/XMLSchema#string

P921

P932

2892443

http://www.w3.org/2001/XMLSchema#string